Ads
related to: top generic drug companies
Search results
Study Raises Concerns About Rising Cost of Diabetes Meds
Medscape· 1 day agoDriven by payments for diabetes treatments — especially insulin — prescription drugs for metabolic...
Vt. economist says no simple fix to easing cost of prescription drugs
WCAX-TV Vermont· 3 days agoThe end of patent protections last year was expected to bring the price down for the drug Humira,...
BCA Research recommends overweight in Pharma as challenges dissipate By Investing.com
Investing.com· 4 days agoBCA Research advises investors to overweight their portfolios in the pharmaceutical sector,...
Top Research Reports for Walt Disney, Charles Schwab & Synopsys
Zacks via Yahoo Finance· 4 days agoToday's Research Daily features new research reports on 16 major stocks, including The Walt Disney ...
3 Stocks That Could Be Easy Wealth Builders
Motley Fool via Yahoo Finance· 2 days agoJohnson & Johnson's financial stability is top-notch, with trailing free cash flows of $18.2 billion. Its generous dividend payments didn't end with the...
Weight-Loss Drugs Are Coming to Bite a Sugar Industry in Denial
Bloomberg via Yahoo Finance· 4 days ago...to Fastest Settlement of Trades in a CenturyIsraeli Airstrike and Egyptian Guard’s Death Ratchet...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
Morningstar· 2 days ago...or otherwise acquired Biogen securities between February 3, 2022 and February 13, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities...
Princeton Bancorp, Inc. (NASDAQ:BPRN) Insider Stephanie Adkins Sells 947 Shares
ETF DAILY NEWS· 1 day agoPrinceton Bancorp, Inc. (NASDAQ:BPRN – Get Free Report) insider Stephanie Adkins sold 947 shares of the business’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average ...
This 5-Star Stock With a Dividend Yield That Tops 4% Is a Buy
Morningstar· 3 days agoGilead Sciences GILD has relied on its HIV and hepatitis C portfolio to drive profit margins. Gilead...
Anti-Obesity Medications: Noteworthy Developments as Policymakers Weigh Coverage Considerations | JD...
JD Supra· 3 days agoGLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and ...